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Harnessing the Placebo Effect:
A New Model for Mind-Body Healing Mechanisms
Gabriel S. Crane

California Institute of Integral Studies
San Francisco, CA, USA
The placebo effect is a phenomenon that has confounded Western medicine and research
for over sixty years. While the field has historically and continues to be rife with
misconceptions and confusion, recent research aims to reignite the art of medicine by
turning the effect's underlying mechanisms to therapeutic benefit. However, researchers
may not have the appropriate theoretical framework to do so. While significant progress
has been made in identifying a number of the placebo effect's underlying mechanisms,
conceptual deficiencies hinder application of advances in the field. In part, this is because
the placebo effect unearths a number of problematic philosophical assumptions inherent
to the biomedical model that inhibit an understanding and harnessing of the placebo
effect in its true potential. This gives cause for these assumptions' reconsideration, within
an understanding that the placebo effect offers evidence of mind-body interaction. With
an eye toward advancing the field of placebo effect research, as well as connect this field
with related fields in mind-body medicine, a new model for understanding the placebo
effect is proposed. Based in transpersonal psychology's participatory model and Daniel
Siegel's mindsight, the placebo effect is defined as any non-pharmacological or mind-based
intervention which positively affects one's energetic and informational patterns, resulting in
improved embodiment and relationship. This article explores how one might arrive at such
a definition and the implications it may hold for placebo-related phenomena.
Keywords: Placebo, placebo effect, expectancy, expectation, meaning, context,
transpersonal, participatory, mindsight, mind-body

I

n the past several years, there has been a surge in
research into the mechanisms underlying the placebo
effect in both scientific research and medical practice
(Colloca, Jonas, Killen, Miller, & Shurtleff, 2015).
Building upon new theoretical models advanced in the
past three decades (Benson & Friedman, 1996; Brody
& Brody, 2000; Harrington, 1997; Kaptchuk, 2002;
Moerman & Jonas, 2002; White, Tursky, & Schwarz,
1985), this research has been driven in large part by
increased interest in the mind-body connection, with a
goal toward harnessing the placebo effect toward greater
therapeutic outcomes in clinical encounters, as well as
improving research methodologies and understanding
the science underlying the phenomenon (Miller,
Colloca, & Kaptchuk, 2009). Indeed, this interest
has been so pronounced that we might “consider the
study of placebos as an emerging scientific discipline”
(Thompson, 2005, p. 15). Since Thompson made this

claim, research and interest has only continued to grow
(Miller et al., 2009; Colloca et al., 2015).
Why all the interest? As Miller et al. (2009)
argued, “Placebo research has the potential to bridge the
chasm between the science and the art of medicine” (p. 12).
The reason for this hinges on the understanding, emerging
in Western medical practice, that “the real success of any
treatment relies on whether it facilitates a positive change
in the patient’s condition” (Medoff & Colloca, 2015, p. 90).
Given the ability of both placebo effects and evidence-based
medicine (EBM) to accomplish this feat, it is becoming
increasingly clear that placebos as broadly defined play a
role in the “repertoire of every healer,” (Thompson, 2005,
p. 11) and that both elements (placebos and EBM) are
essential to providing effective care.
However, while significant progress has been
made in understanding the placebo effect and its
underlying mechanisms, the field has also been hindered
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by misunderstandings about the nature and reality of
the placebo effect, stigmatization within the scientific
and medical communities, and competing theoretical
models that speak to philosophical quandaries underlying
Western science and medical practice (Jonas, 2011; Miller
et al., 2009). These challenges have required researchers
to disentangle core concepts in explaining results to
their audiences, and led many to attempt to relabel the
placebo effect based on a more accurate understanding
of the phenomenon (Brody, 2000; Benson & Friedman,
1996; Moerman & Jonas, 2002; Miller et al., 2009; Di
Blasi & Kleijnen, 2003; Kaptchuk, 2002). While these
attempts have advanced the field, the existing theoretical
frames and proposals nonetheless remain partial and
unsatisfactory. They remain so in part because the
assumptions of the biomedical and Western scientific
model, rooted in Cartesian dualism, remain partly
submerged and unacknowledged and therefore inherent
to the viewpoints advanced. It is here, I will argue, that
the field of transpersonal psychology and its associated
theoretical perspective can make a distinct contribution.
In the following, I will advance the thesis that
contemporary attempts to rename the placebo effect point
to the philosophical assumptions inherent in that term and
the need for their reconsideration. I will argue furthermore
that existing attempts in the field at this reconsideration
are, to date, insufficient, especially when considered
from a transpersonal perspective. After a brief overview
of the placebo effect field and the evolving definitions of
placebo and placebo effect, the major attempts in the field
to relabel the placebo effect will be presented, along with
the main contemporary theories of the placebo effect that
accompany them. A brief exploration of transpersonal
theory will follow, and given its ability to make sense of
different placebo effect theories and connect placebo effect
research with other mind-body fields, the argument will
be made that a transpersonally informed, mind-based,
participatory model is the proper lens through which to
understand and advance research into the placebo effect
at this time. The paper will conclude with a discussion
of the possibilities such revisions indicate and some of the
limitations that remain.
A Historical Overview
of the Placebo Effect
he Western scientific and medical view toward
placebos has traditionally been a negative one. This
is clear when considering that the term placebo, related
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etymologically to placate and meaning “I will please,”
while originating much earlier, came into modern use
with the establishment of the medical clinic in the late
18th century (Finness, Kaptchuk, Miller & Benedetti,
2010). This context, informed by Cartesian dualism and
rooted in evidence-based practices, took placebos and
their effects to refer pejoratively to any treatment that
pleased rather than benefited the patient, in a clinical
sense (Morris, 1997). Thus, from the outset of Western
medical practice, placebo effects have been considered
in some sense “not real.” This view has been accelerated
by the randomized controlled trial (RCT) of the past
60 years, which has, as a natural outgrowth of its focus
on the substance or treatment under study, equated lack
of performance beyond the placebo effect as a failure to
demonstrate treatment value. Even after Henry Beecher's
seminal 1955 article, “The Powerful Placebo,” spoke to
the power of the placebo effect itself, the field has until
recently largely held a dismissive view. This is summed
up by the article, “The placebo: Is it much ado about
nothing?” (Shapiro & Shapiro, 1997), written by two of
the leading researchers in the field at the time, in which
the authors denigrated modern claims of placebo effect
efficacy as “faddish exaggerations” (p. 12) and argued,
“that the current exaggerated belief in the effectiveness
of the placebo (including myriad psychotherapeutic
equivalents) is largely a placebo effect (Shapiro &
Shapiro, 1984)” (p. 27).
Nonetheless, interest in placebos has continued
to boom over the past 30 years, with PubMed citations
of “the placebo effect” growing in the three decades
from 1977 to 2006 from 214 to 651 to 1675 (Miller
& Kaptchuk, 2008). Despite the reticence of many, in
recent years the debate has shifted from whether placebos
work—that is, whether the placebo effect is “real” by
the classical terms of Western medical science (i.e.,
eliciting a physiological rather than purely psychological
response)—to a consideration of how placebos work,
considering the avalanche of data that suggests that
they do (Morris, 1997; Stewart-Williams & Podd, 2004;
Finniss et al., 2010). That an idea, feeling, or relationship
can have a real effect on the body is now established
(Spiegel, 2004). Studies have shown that psychological
factors link to psychoneurobiological mechanisms with
regards to the placebo effect (Beauregard, 2007; Colloca,
Klinger, Flor, & Bingel, 2013). Release of endogenous
neuropeptides such as opioids, cannabinoids, and
dopamine arise in conjunction with placebo responses;
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placebo effects also correlate to specific areas of brain
activity, brain structure, and activity in the frontal lobes,
including activity in the dorsolateral prefrontal cortex
(DLPFC), the rostral anterior cingulate cortex (rACC),
hypothalamus and amygdala (Medoff & Colloca, 2015).
Debate remains as to whether placebos affect illness
(experience of disease) or disease itself (Spiro, 1997), with
some data tending to indicate it is much more the former
(Miller et al., 2009), and some studies continuing to argue
that placebo effects have in fact little clinical significance,
beyond the patient’s experience of pain (Hróbjartsson,
A. & Gøtzsche, P. C., 2010). Nonetheless, despite these
ongoing controversies, “current knowledge of placebo
effects provides direct evidence for mechanisms in the
human brain which can be activated by conscious and
unconscious manipulations of expectations” (Medoff &
Colloca, 2015, p. 94). Beauregard (2007) added that
placebo effects and related subjective processes affect
brain processing and brain plasticity. Taken as a whole,
these emerging discoveries of the past 30 years, greatly
accelerated by advances in brain imaging techniques in the
last decade (Faria, Fredrikson, & Furmark, 2008), “have
given scientific credibility to the placebo phenomenon”
(Benedetti, 2009, p. 75), even as scientists seek more
fully to understand it. In so doing, the placebo effect
has completed its transformation, at least in the research
fields, from a discarded irrelevancy to a “well-recognized
and clinically-important phenomenon,” (Colloca et al.,
2015, p. 1) deserving of research in its own right.
But what exactly are placebo effects? As will be
seen, this shift in appraisal has not resolved much of the
controversy and confusion surrounding them.
Placebo Effects: An Evolving Definition
It is hard to define 'placebo effect' without engaging in a
small-scale project to reform modern medical thinking
(Brody, 1997, p. 79).
he placebo effect does not have a standard definition
(Miller et al., 2009). As Brody's quote indicates,
definitions are inherently and historically difficult when it
comes to placebos and placebo effects (Stewart-Williams
& Podd, 2004). This is due partly to the misconceptions
and biases outlined above, partly to the self-contradictory
nature of placebos as they have traditionally been
conceived, and partly to the philosophical shortcomings
of the cultural mind that conceived of them as such.
While placebos have been defined as something inert,
and therefore by definition unable to elicit an effect, they

nonetheless do elicit effects, which are then called the
placebo effect (Finness et al., 2010). This renders the
term placebo effect an oxymoron. As Moerman and Jonas
(2002) pointed out, “The one thing of which we can be
absolutely certain is that placebos do not cause placebo
effects. Placebos are inert and don’t cause anything” (p.
471).
Among others, Miller and Kaptchuk (2008)
provided a sound overview of the problems such issues
cause, including a number of the assumptions and
quandaries they unearth. These include: 1) an unscientific
tendency to define placebo treatments as nonspecific and
inert; 2) the tendency to equate placebo treatments with
“no treatment”; 3) the subsequent devaluation of the
placebo effect as a “sham,” “noise,” and/or “bias”; 4) the
notion of a singular “placebo effect” when research has
shown there are multiple biological and psychological
pathways for placebo effects to take place; 5) the view
that the utilization of placebos, whatever their form,
is unethical and deceptive; 6) the mistaken belief that
placebo treatments are necessarily causally linked to
subsequent effect; and 7) the resultant confusion and
generally negative and distrustful orientation that the
above factors help to generate. To these it should be
added (and indeed much of the above could be couched
within) the medical model's historical assumption of
Cartesian dualism, separation of subjective and objective
phenomena and dismissal of the subjective, and
subsequent inability to conceptualize how psychological
and physiological factors might interrelate (Engel, 1992).
Due to the psychosomatic premise placebo effects
advance, the conditions for misconception are ripe.
The limitations described here have led scholars
in two interrelated directions: first, the qualification of the
placebo effect as a temporary (Spiro, 1997), “wastebucket
term” (Brody, 1997, p. 89), used “to refer to any effect for
which we have no mechanistic explanation” (Ader, 1997,
p. 138); and, second, the search for new terminology
and theoretical frameworks to describe and make sense
of these phenomena. Noting the “lack of any theoretical
positions(s) within which to organize data” (Ader, 1997,
p. 138), and that “the poverty of theory has continued to
characterize placebo research” (Miller et al., 2009, p. 1),
a number of proposals have been made for renaming the
placebo effect. These have included: “placebo response”
and “inner pharmacy” within the context of a “meaning
model” (Brody, 2000); “remembered wellness” (Benson
& Friedman, 1996); “meaning response” (Moerman
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& Jonas, 2002; Walach & Jonas, 2004); “contextbased healing” (Kaptchuk, 2002); “contextual healing”
(Miller & Kaptchuk, 2008); “context effects” (Di Blasi
& Kleijnen, 2003); and, “interpersonal healing” (Miller
et al., 2009). As Colloca et al. (2015) summarized, “The
study of the placebo effect is increasingly being framed
as the investigation of the psychosocial context and
inner factors surrounding the patient and any medical
treatments, and the effect of this context on the patient's
mind, brain and body when one expects a therapeutic
benefit” (p. 2).
Nonetheless, despite these proposed definitions,
placebos and the placebo effect are so culturally significant
and recognizable as terms that they are unlikely to be
disposed of soon (Miller et al., 2009). Therefore, for the
sake of common understanding, and due to the fact that
this paper in large part deals with the theoretical and
philosophical conceptions that these terms reflect, I will
use the terms placebo and placebo effect to refer to those
phenomena indicated by all the suggested terms above.
While this phenomenon is elusive, I will here as a working
definition use placebo to refer to treatment interventions
lacking in pharmacological and physiological properties
known to treat a specific condition in question. I will define
the placebo effect and placebo effects as any physiologically
evident healing effect that originates from the mind. While
this definition implicitly suggests a dualism of mind
and physiology that could be considered problematic
(Hartelius & Ferrer, 2013; Tarnas, 1991), it is nonetheless
sufficient and appropriate for the subject matter presented
here, due to its particular usefulness in making sense of
causal relationships and mechanisms involved in placebo
effects as they are generally understood today. This issue
can partially be addressed by defining mind, by which
I mean that definition forwarded by Daniel Siegel: “a
relational and embodied process that regulates the flow of
energy and information” (Siegel, 2010, p. 52, emphasis
added). In addition, issues of dualism will be addressed
in the discussion. With these definitions established,
it is now possible to disentangling the complex notions
ensnaring the placebo effect.
Disentangling the Placebo Effect
and Identifying Root Causes
onsideration of two specific distinctions will aid
in a constructive reframing of placebo effects:
expectancy versus conditioning, and context versus
meaning.
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Expectancy versus Conditioning
One of the primary subjects of debate regarding
the placebo effect is the mechanism by which it is
expressed. Until new advances in recent years, this
has largely revolved around the debate of classical
conditioning versus expectancy theory (Price & Fields,
1997; Fields & Price, 1997; Stewart-Williams & Podd,
2004). From the viewpoint of classical conditioning,
placebo effects take place because the placebo recipient is
conditioned from past experience to experience healing
in a certain circumstance, for example when taking a
medical pill administered by a doctor, or in carrying
out a clinician-recommended protocol. The repeated
association of a neutral stimulus (the placebo) with an
active healing agent (unconditioned stimulus) can later
result in the neutral stimulus bringing forth the effects
expected from the unconditioned stimulus (Finniss et
al., 2010). Here, in a classical Pavlovian framework,
the placebo recipient unconsciously responds based on a
previous coupling of active and inactive agents, and then
acts based upon these established patterns.
By contrast, in expectancy theory it is the
placebo recipient's expectation of healing that brings
about the placebo effect. This is sometimes expanded
to include the recipients desire to heal (Price & Fields,
1997), and can be elicited via verbal instruction, learning,
and social factors (Medell & Colloca, 2015). This can
be distinguished from classical conditioning on the basis
that no prior experience with the particular stimuli in
question is necessarily needed to elicit the placebo effect.
As Price and Fields argued, “expectation for relief may
cause a placebo response without prior exposure to a
therapeutic agent” (p. 123). In other words, positive
thinking is not a sham: expecting a positive outcome will
more likely yield one, and the placebo effect is the data
to back it up. This principle is clearly demonstrated in
the now well-known study (Crum & Langer, 2007) of
female hotel room attendants who were taught how their
regular work amounted to healthy exercise, meeting or
exceeding the Surgeon General's requirements, and then
were compared to a control group that was not given
such information. While both groups' activity remained
the same, over the course of the study the percentage of
the informed subjects who reported exercising regularly
doubled, the amount of exercise they perceived to be
getting increased by 20 percent, and these shifts in
mind-set were correlated by statistically significant
improvements in their physiological health not exhibited
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by the control. From an expectancy perspective, these
changes were brought about by simple education and
verbal and social cues.
This debate between classical conditioning
and expectancy can be characterized from one vantage
point as a debate over the level of active involvement the
placebo recipient plays in the generation of the placebo
effect. In expectancy theory, the recipient plays a more
active role in eliciting the placebo effect, while in classical
conditioning, the recipient is more of a passive agent
at the disposal of unconscious forces. While disguised
within arguments over mechanism, elements of the
Cartesian debate can here be seen at play. The classical
conditioning viewpoint, being predisposed to ascribe a
passive role to the patient can imagine the patient as being
misled by the illusory effects of the inert placebo. This
allows implicitly for a continued dismissal of subjective
experience and phenomena. By contrast, the expectancy
model explicitly empowers the patient as an active agent
in her own healing, thus suggesting that one's subjective,
conscious experience may play a role in shaping one's
reality. This shift from passive fool to empowered actor
is summed up by Price and Fields (1997):

Thus, in the question of classical conditioning
versus expectancy, one encounters the divide between
the passive patient, the fooled recipient who exhibits
the placebo effect (embarrassingly), and the active
participant, who with superior awareness and knowledge
wields the power of mind to affect physiology, experience,
and indeed, reality.
This debate has resulted simultaneously in two
outcomes: a victory for expectancy, and a draw. While
expectations, desires, and other related factors are
definitely mechanisms for the placebo effect, so is, at
times, classical conditioning (Finniss et al., 2010). Brody
(2000) has argued that the two mechanisms may simply
be describing the same process from different vantage

points, as expectations can arise as a result of learning
(conditioning), and, if yielding of results, will also
contribute to future conditioning. Classical conditioning
and expectancy are now most commonly described
as compatible (Stewart-Williams & Podd, 2004) and
entangled (Finniss et al., 2010), with recent research
suggesting that “expectancy is first, conditioning follows
and is dependent on the success of the first encounter”
(Finniss et al., 2010, p. 3). That said, considering the
constant conditioning taking place within culture, it is
easily possible to reverse this order, especially outside of
a controlled research environment.
To summarize it simply from another view,
placebo effects are sometimes mediated by conscious
experience (expectancy+conditioning), and sometimes
not (pure conditioning; Stewart-Williams & Podd,
2004). Nonetheless, while both mechanisms are now
accepted as causes of placebo effects (the draw), this
remains a victory for expectancy proponents, as, (most
crucially, from a transpersonal viewpoint), the active
agency of the human subject in eliciting placebo effects
is, among other mechanisms, sometimes, affirmed.
Context versus Meaning
With the above debate between expectancy and
classical conditioning to some extent resolved, researchers
have attempted more recently to construct suitable
theories for the placebo effect that stray increasingly from
the traditional domain of biomedicine. These theories
increasingly recognize both the ability of the placebo
recipient to elicit self-healing responses (Reilly, 2001), and
for the placebo administrator and environment to affect
healing via contextual and interpersonal means (Miller
et al., 2009). As noted above, these new frameworks
have been accompanied by attempts to rename the
placebo effect, with the main proposals falling into two
main camps—the “meaning response” (Brody, 1997;
Brody, 2000; Moerman & Jonas, 2002; Walach &
Jonas, 2004) and “contextual healing” (Kaptchuk, 2002;
Miller & Kaptchuk, 2008; Di Blasi & Kleijnen, 2003),
also sometimes characterized as “interpersonal healing”
(Miller et al., 2009).
The meaning response is advanced by Brody
(2000) as the placebo effect that occurs when the meaning
associated with illness is positively transformed. This is
based on an understanding of the placebo not merely as
a pill or even procedure but as a symbol (Spiro, 1997)
that acquires meaning through previous learning (Fields
& Price, 1997). Moerman & Jonas (2002) brought
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Suppose the experiential factors that are necessary and
sufficient for the placebo effect become established
and well-characterized. Knowledge of these factors
could then be more directly and optimally utilized
by both patients and healthcare providers. The
concept of "placebo manipulations" would shift in
emphasis from reliance on outside authority to the
patients' active participation in developing optimal
psychological conditions for therapeutic effects. (p.
134)

the example of red pills versus blue holding different
significances (red generally meaning hot and fast, blue
meaning cold and relaxed) and therefore eliciting different
responses, even if the pills are both placebos in the
classical sense. The same principle can extend to quantity
(two pills have more impact than one), and a host of other
factors. Given that most information humans are privy to
is ignored due to its sheer volume, altering our symbolic
attachments and interpretations (i.e., influencing which
information is taken in and how it is taken in) can
elicit changed outcomes (Brody, 2000). This could be
understood as well as the meaningful interpretation
of symbols within the context of a coherent, satisfying
narrative, making it largely compatible with theories of
many disciplines in the humanities. For example, this
interpretation shares obvious, though unfortunately
unacknowledged views with humanistic psychology and
its conceptions of the importance of meaning to human
experience (Frankl, 1959; Battista & Almond, 1973).
By contrast, Miller et al. (2009) critiqued the
meaning response as overly broad and suggestive of
an “explanatory psychosocial hypothesis” (p. 8) that
requires cognitive interpretation and therefore leaves
some mechanisms of the placebo effect, for example,
classical conditioning, unaddressed. In its place, they
suggested “interpersonal healing,” which can be linked
generally to other definitions related to context. These
models emphasize the role of the therapeutic relationship
between clinician and patient in eliciting the placebo
effect (Colloca et al., 2015; Spiegel, 2004), and suggest
that social and environmental factors are the main
generators of expectancies that cue healing. From the
viewpoint of context-based theories, placebo effects are
the result of healing rituals (Kaptchuk, 2002) that take
place within a complex cultural web. This prompts the
observation that “social-cultural-psychological events
have physiological aspects” (Hahn, 1997, p. 71), and that
“humans activate the neurobiological circuits required
for placebo effects through the subtle and diffuse
experience of living within the inescapably meaningrich domain of culture” (Morris, 1997, p. 189). This is
furthermore a basis suggested for the efficacy of some
complementary and alternative medicines (Kaptchuk,
2002; Reilly, 2001). Interestingly enough, these models
also overlap with a humanistic viewpoint in their
emphasis on the therapeutic relationship (Elkins, 2007;
Elkins, 2008; Lambert & Barley, 2001). However, as
will be seen in the next section, this relationship is not
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mere coincidence. Indeed, a deeper understanding of the
mechanisms at play is greatly aided by the humanistic
movement's friend and offspring, transpersonal
psychology.
Discussion: Transpersonal Reconceptions,
Possibilities, and Limitations
f the placebo effect can be reconceptualized with
the use of particiatory elements from contemporary
transpersonal theory, this may lead to more useful
characterizations. It may also aid in developing measured
characerizations of the phenomenon that neither dismiss
nor uncritically exaggerate its potentials.
Transpersonal Reconceptions
of Placebo Effect Theories
As seen above, the placebo effect has already
poked holes in Western medicine's traditional distinction between mind and body (Brody, 1997; Fields &
Price, 1997). Clearly, subject and object influence one
another, and as emerging models for the placebo effect
demonstrate, the ability of the mind to affect physiology,
whether through expectancy, meaning, or context, is
increasingly accepted. However, the full implications
and potential of these developments might not be clear
without taking into account a transpersonal perspective.
While the exact mechanisms of mind-body interaction
may remain unclear for quite some time, there is much
one can already gain through a brief theoretical inquiry.
Firstly, by more closely examining the context/
meaning debate in contemporary placebo effect research,
one can see that it too, like the conditioning/expectancy
debate before it, may be a result of complementary
rather than competing attempts to describe the same
phenomenon. This viewpoint is one transpersonal
psychology is particularly well-situated to articulate,
considering the recent emergence of participatory theory
(Ferrer, 2002; Hartelius & Ferrer, 2013), which can be
interpreted to suggest that all meaning is inherently
contextual. To arrive at this understanding, we can
begin by understanding that participatory theory
presents “a substantive challenge to Cartesian dualism”
(Hartelius & Ferrer, p. 15). It does so by arguing that
rather than being inherently separate, “mind and nature
are necessarily woven of the same fabric” (p. 16). Rather
than a materialistic dualism that treats reality as inert,
reality is seen as in some way sentient and alive, with
both subjective and objective aspects of experience
emerging from a shared mystery.

I
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This may seem highly theoretical, whimsical
even, but it is useful when examining the placebo
effect theories encountered above. Following the
reasoning of the meaning-based proponents above, the
mind activates meaning through the interpretation of
received information, whether in the form of expectancy
or prior conditioning. However, in the context of
participatory theory, this does not take place in an
abstract, metaphysical vacuum, as Cartesian dualism
would suggest. Rather, this process “is woven back into
the fabric of life... [the ego] is no longer the observer
who can take in the whole painting from afar; it is
part of the canvas, and it is located on that canvas” (p.
19). Indeed, the ego “cannot escape its locatedness” (p.
19), which, framed in the terms of our current debate,
is to say, its context. If one understands the ego to be
synonymous in this instance with the meaning-making
mind posited above, it can be deduced that the mind's
understanding of meaning is therefore inseparable and
derived in part from its context. The mind is part of
reality. It is embedded within it; enmeshed. In this way,
the interrelatedness of meaning and context becomes
clear. In other words, placebos are meaningful symbols
that become expressed through relational contexts.
This reconception of prevailing placebo effect
theories can potentially provide the field with a coherent
theoretical frame that synthesizes context and meaning.
However, it may be possible to expand upon this further
to advance a reconceived definition of the placebo effect
that speaks more fully to its true potential. This can
be done by first returning to Siegel's (2010)definition
of mind. In doing so, it should be noted that while
mind and subjective-based factors are implicit in many
of the emerging terminologies proposed in the study of
placebo effects, the explicit naming of mind is virtually
nonexistent. This may be due in part to the medical
model's uneasiness with the term. Nonetheless, research
has shown that the mind, through its expectations and
other subjective factors, can manifest its aims across
a range of neurobiological mechanisms (Finniss et
al., 2010). Placebo-induced pain relief, for example,
involves the release of endogenous neuropeptides,
but placebo-induced relief from addiction involves
metabolic changes in different brain regions (Volkow
et al., 2003), and for Alzheimer's the mechanism
involves functional connectivity in prefontal areas and
prefrontal executive control (Benedetti et al., 2006). The
physiological mechanism changes, but the mind remains

constant. Therefore, mind as it is understood here is an
indispensable factor.
With this established, it is possible to turn
to consider the nature of expectations. Given that
expectancy is derived from verbal and social cues that
convey information, as well as learned conditions
(conditioning) from information conveyed in the past,
it is clear that expectancy is essentially an informational
model (Kirsch, 1997). This emphasis on information is a
useful building block in constructing an understanding
of “mind,” and indeed corroborates to Siegel’s (2010)
definition of the mind as “a relational and embodied
process that regulates the flow of energy and information”
(p. 52). Because this information is not abstract but
rather embodied and embedded within relational vectors,
the transformation of this information will necessarily
impact these factors of the mind’s process. Changes in
information will cause physical changes and changes in
physical experience, because here the mind is not above,
separate from, or interpreting the body, but is itself part
of it. Relationality and embodiment are intertwined,
as are energy and information; thus, it is natural that
informational regulation (e.g., in the form of placebos)
simultaneously affects the mind's embodiment, which
in turn triggers changes in the energetic vector as well
(i.e., eliciting a physical or psychosomatic response).
From this vantage point, while meaning and context are
crucial enablers of the placebo effect, both serve only as
indirect proxy to the patterns by which information and
energy transform and interrelate. Through conscious
intervention, perhaps via meaning and context but also
possibly directly, these patterns can be changed positively
and guided toward healing outcomes. Thus, the placebo
effect becomes any non-pharmacological or mind-based
intervention that positively affects one's energetic and
informational patterns, resulting in improved embodiment
and relationship. On the whole, I would argue that this
is a more direct, precise, and sensible definition than
those existing proposals advanced by researchers in the
field.
New and Improved:
Possibilities for the Placebo Effect in Action
The above reconception is not mere
philosophical rhetoric and hot air. On the contrary, such
a theoretical framing is crucially important, as it allows
for the placebo effect to extend beyond its conventional
context and become connected with other mind-based,
healing phenomena. This in turn creates a new lens
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through which to understand such phenomena, as well
as the prospect for potentially harnessing the placebo
effect to a greater degree than is currently understood
as possible. While rituals and clinical encounters allow
access to new meaning (information) through context,
the placebo effect may not be limited to these relational
tropes. Indeed, there may already be a number of useful
interventions a patient can undertake on their own to
activate self-healing (for example, meditation, positive
thinking, self-directed healing rituals, mind-focusing
activities, invoking of certain healing qualities and
information, etc.). These practices in turn overlap with
other mind-based interventions such as mindfulnessbased stress reduction, somatic practices such as yoga
and qigong, and biofield therapies such as distance
healing, qi therapy, energy healing, and so on, allowing
for a theoretical coherence between placebo effects
and other alternative practices that can guide research
and may advance understanding of these practices,
as well as create opportunity for their improvement.
While a discussion of ethical considerations involved
in the clinical application of placebo effects extends
beyond the scope of this paper, it is worth noting that
the unifying theoretical model advanced here links
placebo responses with complementary and alternative
medicines (CAM), as well as research in the emerging
field of biofield therapies (Rubik, 2015; Rubik,
Muehsam, Hammerschlag, & Jain, 2015; Kreitzer &
Saper, 2015). As such, a number of healing “placebo”
or complementary and alternative applications can be
understood as useful interventions that sidestep any
need for subterfuge or deceit.
In so doing, it may be possible to inquire more
scientifically into the nature of practices traditionally
understood as nonscientific. Insofar as faith and hope
“implicitly contain the dimensions of need or desire and
expectation” (Price & Fields, 1997, p. 128), the placebo
effect can also be understood as a manifestation of socalled “faith healing.” From the transpersonal vantage
point articulated here, placebo effects might therefore be
understood as the scientific demonstrations of supposed
miraculous and religiously-based healing experiences.
Framed in these terms, it is easy to understand how
modern science, considering its cultural assumptions
and historical location, would be primed to dismiss
placebo effect-related phenomena. However, rather than
delegitimize science, the placebo effect when properly
understood provides an opportunity to understand
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more clearly the true factors and science at play in
faith healing, and even improve upon them. Faith and
hope, for example, may both be limited by their nature
as nonspecific factors (Kirsch, 1997). Information, by
contrast, can be very specific. By marshalling faith and
hope within the context of the embodied and relational
mind, it may be possible to access and manipulate specific
information to enact specific energetic and physiological
responses that approximate or exceed those of faith
healing “miracles.”
Similarly, this synthesized transpersonal
viewpoint might facilitate improved dialogue between
conventional and alternative and complementary
medicines (CAM). It is, after all, possibly due in part
to the public's renewed interested in CAM that placebo
effect research has increased (Kaptchuk, 2002; Reilly,
2001). Understanding the underlying mechanisms
proposed here, namely the changing of energy and
information through relational and embodied practices,
might significantly reduce confusion and malpractice
and streamline the ability to understand and harness the
tools CAM and biofield therapies provide. As wholeperson care becomes more scientifically necessary (Reilly,
2001), and as conventional training leaves many Western
doctors lacking in this regard, the mechanisms and tools
of integrative treatments have migrated to the center of
the contemporary medical conversation. While from a
conventional Western viewpoint it remains unclear how
understanding of the placebo effect's mechanisms might
translate into clinical tools (Medoff & Colloca, 2015),
CAM and biofield therapies can offer a number of readymade practices, developed in some cases over centuries
and millennia, that can be submitted for research and
compared within this theoretical frame.
This is a time of exploding healthcare costs that
is marked by an over-reliance on so-called evidence-based
treatments. Research now suggests that antidepressants
are perhaps no more impactful than placebo effects
(Kirsch, 2010; Kirsch & Sapirstein, 1998), and cognitive
therapies, once the darling of empirically-supported
treatments, are arguably no more effective than the
therapeutic alliance, which was of course dismissed
as a placebo (Elkins, 2007). In such a climate, how
profoundly valuable might it be to know that the
healthiest thing you could do for yourself today might be
to simply invoke positive information such as gratitude,
openness, harmony and love, while feeling into your
body and heart and the world around you.
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Limitations to Placebo Enthusiasm
All that said, there are limitations to place on
placebo enthusiasm. This should be expected with any
discipline that has been subject to as much challenge and
confusion as this one has, over such an extended period
of time. It can legitimately be asked, despite theoretical
cohesion, whether we can talk about “a neurobiology of
meaning” (Brody, 1997, p. 85) at the level of specificity
proposed here. It remains to be seen, for example, whether
expecting the release of neuropeptides can trigger such
exact responses, or whether the average clinician, trained
in the prevailing medical models of the day, will have
the interest, energy, and time to apply placebo-based
protocols, or even the ability to comprehend what
might appear, on first glance, as esoteric and far-flung.
Meanwhile, from the patient's standpoint, there are
almost certainly limitations to expectation and desire for
relief. Perhaps not if one expect differently and really
wants it(!), but until further notice, it is safe to assume
that the physical world exerts constraints on the mind as
much as minds constrain the physical world (Gazzaniga,
2011). While our minds, especially when more fully
understood and utilized, may be able to affect a great
deal, there will likely still remain a great deal beyond
individual or even collective control.
One vector by which to understand this is
the distinction between illness and disease. As Spiro
(1997) articulated, “disease is what the doctor sees and
finds, illness is what the patient feels and suffers” (p.
45). While this distinction has “fuzzy borders,” (p. 45),
existing research has seemed to indicate for the most
part that the placebo effect can help heal illness, but may
not contribute as significantly to the curing of disease
(Miller et al., 2009). While these results may be due in
part to the unacknowledged contextual biases of culture
present in these studies, they would nonetheless seem
to be corroborated by the centuries of largely placebobased medicine (Shapiro & Shapiro, 1997) that gave rise
to the need for evidence-based medicine to begin with.
Conventional wisdom suggests that there must be a point
at which a certain New Age trope has taken hold, and in
one's belief in and yearning for placebo effects, one loses
touch with the true ground of reality.
If so, however, where is that point? It is not
so easily identifiable or defined. After all, there is not
much about placebo effects that has proven conventional
to date. Might it be possible that the “distinction
between 'disease' and 'illness' is circular” (Harrington,
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1997, p. 213), with no definite point at which they
intersect? Can disease be something “solidly biological
and intransigent” (p. 213), with no psychological factor,
if the integrated nature of reality suggests that such a
notion is a paradox? Could it be possible that disease is
partly wrought through “the whole process of diagnosis
and objectification,” (p. 213-4), begging the question “of
whether, so to speak, there can be a 'disease' falling in
the woods with no one there to hear it?” (p. 214). There
are, after all, contested reports of tumors shrinking
through Qigong therapy (Ooi, Simm, & Tann, 2013),
less contested accounts that placebo effects have
extended even to the realm of surgery (Dimond, Kittle,
& Crockett,1960; Cobb, Thomas, Dillard, Merendino,
& Bruce, 1959), and serious consideration of the notion
that placebo effects might have the capacity to affect
pathophysiological effects as significant as cancer (Price
& Fields, 1997). It may be, as research progresses in this
field, that even limitations have their limit.
Finally, it bears mentioning the most obvious
and critical limitation, if also unfortunately the
most commonly transgressed: retaining a respect
and appreciation for both the placebo effects and the
evidence-based treatments that good, reputable science
demonstrates. While this discussion has touched upon
the tendency for Western clinicians to eschew placebo
effects for pure EBM, it is equally important to name
the tendency of many people, particularly spirituallyoriented individuals and alternative practitioners, to
eschew EBM for pure placebo effects. In this regard, the
problem with substituting placebo effects for evidencebased treatments, rather than utilizing the two in
tandem, cannot be overstressed. Such an approach can
be harmful and deceitful both to oneself and others, and
cause much unnecessary suffering and confusion, not to
mention reinforce conventional biases around placebo
effects.
Conclusion
enewed interest in and research into the placebo effect
have yielded much new understanding as to both
the mind-based and physiological mechanisms involved
in the phenomenon. At the same time, these discoveries
have highlighted challenges with some of the core
assumptions underlying the Western biomedical model,
and spawned the need for their reconsideration. As this
paper has sought to demonstrate, these reconsiderations
are best undertaken by the lens provided by emerging
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transpersonal theories, including participatory philosophy
and a meaning- and context-based understanding of
mind as a regulator of energy and information. On the
whole, such perspectives allow for the placebo effect
to be understood as any non-pharmacological or mindbased intervention that positively affects one’s energetic and
informational patterns, resulting in improved embodiment
and relationship. This definition resolves past issues
between the expectancy and conditioning camps, as well
as meaning and context perspectives, in that it does not
assume a dualistic distinction between mind and body,
and acknowledges the ways in which mind and matter
are intertwined and mutually influencing. Through the
coherence such a definition provides, it may be possible
to make advances in our understanding of the placebo
effect and its connection to complementary healing
practices and biofield therapies, bridge the gaps between
conventional and alternative medicines, and enhance our
ability to unlock the mind-body unity's innate healing
capacities. Given the rising cost of health care and the
increasing interest in alternative and complementary
medicine, such advances would be exceedingly timely
and welcomed.
Finally, in closing, one secondary implication
of participatory theory suggests both constraints and
directions for further placebo research. This is that the
locatedness of mind demonstrates, as researchers have
begun to identify, that there is no singular, universal
placebo effect. There are instead placebo effects, and
these will vary infinitely based upon the infinite positions
of locatedness existing in reality. As Spiro (1997) wisely
names, “How placebos are defined will depend ... . One
person's placebo effect is another's active agent” (p. 44).
Debates in the field of placebo effects such as those
described above, based around the attempt to define,
universally, how placebo effects work, are therefore in
some respect nonsensical. While the seeking for an
absolute truth has been of service in exploring material
reality, such an approach rarely goes as well when applied
to the subjective or psychological domain. Such evolving
understandings may continue to influence the type of
information considered to be valid or positive, the
conception and definition of our research goals, and the
manner in which energy is exerted to pursue them.
On that note, it is worth offering a few brief
thoughts as to the direction future research in this field
might take. While one can expect significant advances
to continue to emerge in the field, even within the next
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few years (Medoff & Colloca, 2015), I maintain that the
exact mechanisms and nature of the phenomena now
known as the placebo effect will remain essentially, and
necessarily, mysterious. This is because ultimately, such
mechanisms arise from a paradoxical mystery (Hartelius
& Ferrer, 2013) that is at once necessary to understand
and approach and simultaneously incomprehensible and
unattainable. While this might frustrate contemporary
orientations toward progress and solutions, and may
indeed sound to many like nonsense, mystery is one
element of ancient understandings that could perhaps be
better integrated into modern lives (Brody, 2000). While
advances in understanding the placebo effect certainly do
offer the opportunity “to pull back the veil surrounding
the art of medicine, by elucidating the way in which
specific contextual factors in the clinical encounter
contribute to therapeutic outcomes” (Miller & Kaptchuk,
2008, p. 224), one should pursue these understandings
while keeping an eye to the vanishing point from
which all epistemologies arise. While it is unnecessary
to go on at length with regards to metaphysics, they
nonetheless bear mentioning if unconscious attempts
at absolute claims cannot be entirely quarried. In that
regard, essential mysteriousness and paradox are, by
my estimation, about the only metaphysical absolutes
worth claiming. Certainly, understanding will advance,
but just as certainly, there will always be some curious
element that refuses to fit in the box.
This is not something to bemoan. Rather, I
maintain, it is a good, health-promoting understanding
that is to be cherished for its empirically demonstrable
benefits. Acceptance, harmony, and equanimity are
all qualities with which we can more meaningfully
and beautifully, and therefore more healthfully, meet
those aspects of existence that remain beyond our
understanding and control. This too is a form of
contextual healing. It arises with creativity and respect
out of the living, intersubjective engagement with this
paradoxical quandary, and its attendant uncertainty, that
underlies all of life, and from which the inner pharmacy
emerges and all innate healing capacities grow.
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